Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Constantin A. Dasanu, Juliana Alvarez-Argote & Catherine B Goff. (2022) Selecting appropriate therapy for hairy cell leukemia: current state and future prospects based on molecularly defined characterization. Expert Opinion on Pharmacotherapy 23:11, pages 1239-1241.
Read now
Read now
Richard Nicholas, Paolo Giannetti, Ali Alsanousi, Tim Friede & Paolo A Muraro. (2011) Development of oral immunomodulatory agents in the management of multiple sclerosis. Drug Design, Development and Therapy 5, pages 255-274.
Read now
Read now
Articles from other publishers (11)
Robert J. Kreitman, Philippe Moreau, Farhad Ravandi, Martin Hutchings, Anas Gazzah, Anne-Sophie Michallet, Zev A. Wainberg, Alexander Stein, Sascha Dietrich, Maja J. A. de Jonge, Wolfgang Willenbacher, Jacques De Grève, Evgeny Arons, Palanichamy Ilankumaran, Paul Burgess, Eduard Gasal & Vivek Subbiah. (2023)
Dabrafenib plus trametinib in patients with relapsed/refractory
BRAF
V600E mutation–positive hairy cell leukemia
. Blood 141:9, pages 996-1006.
Crossref
Crossref
Nikolaos Markoglou, George Simeakis, Maria Alevizaki, Georgios Velonakis, Theofanis Chatzistamatiou, Maria Spyropoulou-Vlachou, Catherine Stavropoulos-Giokas, Leonidas Stefanis & Maria Anagnostouli. (2022) Multiple Sclerosis and MEN2 Neoplasia in a Female Patient: A Unique Co-Existence with Expanded Immunological Interest and Therapeutical Challenges, before and after Patient’s COVID-19 Infection. Biomedicines 10:11, pages 2850.
Crossref
Crossref
Tagrid Younes Ahmad, Hasan Nabil Al Houri, Sami Jomaa, Wisam Assad & Sarah Zaher Addeen. (2022) Primary splenic T-cell/histiocyte-rich B-cell lymphoma in a patient with recurrent hairy cell leukemia: a case report. Oxford Medical Case Reports 2022:11.
Crossref
Crossref
Esther Melamed & Michael William Lee. (2020) Multiple Sclerosis and Cancer: The Ying-Yang Effect of Disease Modifying Therapies. Frontiers in Immunology 10.
Crossref
Crossref
Frank J Senatore & Constantin A Dasanu. (2015) Synchronous gastric and ampullary adenocarcinomas in a hairy cell leukemia patient treated with pentostatin eight years prior. Journal of Oncology Pharmacy Practice 22:3, pages 543-547.
Crossref
Crossref
K. Akinosoglou, M. Melachrinou, T. Makatsoris, M. Sakellakis, C. Papakonstantinou, C. A. Gogos & E. E. Solomou. (2015) Rituximab as frontline monotherapy in untreated hairy cell leukemia patients. Annals of Hematology 94:6, pages 1069-1070.
Crossref
Crossref
Michael R. Grever, James S. Blachly & Leslie A. Andritsos. (2014) Hairy cell leukemia: Update on molecular profiling and therapeutic advances. Blood Reviews 28:5, pages 197-203.
Crossref
Crossref
Preetesh Jain, Naveen Pemmaraju & Farhad Ravandi. (2014) Update on the Biology and Treatment Options for Hairy Cell Leukemia. Current Treatment Options in Oncology 15:2, pages 187-209.
Crossref
Crossref
Mikhail Roshal & Sindhu Cherian. (2012) Frequency of additional clonal populations detected by high sensitivity flow cytometry in patients with hairy cell leukemia. Journal of Hematopathology 5:3, pages 123-130.
Crossref
Crossref
Genevieve M. Weir, Robert S. Liwski & Marc Mansour. (2011) Immune Modulation by Chemotherapy or Immunotherapy to Enhance Cancer Vaccines. Cancers 3:3, pages 3114-3142.
Crossref
Crossref
Constantin A. Dasanu, Michael A. Reale & Frank Bauer. (2010) Mantle cell lymphoma arising in a multiple myeloma patient responding to lenalidomide. Leukemia Research 34:7, pages e178-e180.
Crossref
Crossref